These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 195378)

  • 21. Impairment of synaptic vesicle exocytosis and recycling during neuromuscular weakness produced in mice by 2,4-dithiobiuret.
    Xu YF; Autio D; Rheuben MB; Atchison WD
    J Neurophysiol; 2002 Dec; 88(6):3243-58. PubMed ID: 12466444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracellular acetylcholinesterase of adult rat myofibers is more concentrated in endplate than non-endplate regions.
    Donoso JA; Stiles JR; Fernandez HL
    J Neurosci Res; 1987; 17(2):146-53. PubMed ID: 3586068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Glucose-6-phosphate dehydrogenase in the motor endplate and autonomic terminal fibers].
    Winckler J
    Acta Histochem Suppl; 1975; 14():179-84. PubMed ID: 829985
    [No Abstract]   [Full Text] [Related]  

  • 24. Cholinesterases of the motor end-plate of the rat diaphragm.
    Brzin M; Kiauta T
    Prog Brain Res; 1979; 49():313-22. PubMed ID: 515435
    [No Abstract]   [Full Text] [Related]  

  • 25. Congenital myasthenia: end-plate acetylcholine receptors and electrophysiology in five cases.
    Vincent A; Cull-Candy SG; Newsom-Davis J; Trautmann A; Molenaar PC; Polak RL
    Muscle Nerve; 1981; 4(4):306-18. PubMed ID: 7254233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diseases of the motoric end plate including myasthenia gravis].
    Struppler A
    Wien Klin Wochenschr; 1967 Aug; 79(33):620-2. PubMed ID: 4298887
    [No Abstract]   [Full Text] [Related]  

  • 27. [Congenital diseases of neuromuscular transmission: congenital myasthenia syndromes].
    Sieb JP
    Nervenarzt; 1995 Feb; 66(2):105-10. PubMed ID: 7715748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence of a dosage effect and a physiological endplate acetylcholinesterase deficiency in the first mouse models mimicking Schwartz-Jampel syndrome neuromyotonia.
    Stum M; Girard E; Bangratz M; Bernard V; Herbin M; Vignaud A; Ferry A; Davoine CS; Echaniz-Laguna A; René F; Marcel C; Molgó J; Fontaine B; Krejci E; Nicole S
    Hum Mol Genet; 2008 Oct; 17(20):3166-79. PubMed ID: 18647752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Passive transfer of the Lambert-Eaton myasthenic syndrome: neuromuscular transmission in mice injected with plasma.
    Kim YI
    Muscle Nerve; 1985 Feb; 8(2):162-72. PubMed ID: 2997605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies of the in situ acetylcholinesterase of motor endplate. Functional correlation and inhibition by various cholinergic ligands.
    Chang CC; Su MJ
    Taiwan Yi Xue Hui Za Zhi; 1982 Jul; 81(7):868-77. PubMed ID: 6958812
    [No Abstract]   [Full Text] [Related]  

  • 31. Recently recognized congenital myasthenic syndromes: (a) end-plate acetylcholine (ACh) esterase deficiency (b) putative abnormality of the ACh induced ion channel (c) putative defect of ACh resynthesis or mobilization - clinical features, ultrastructure and cytochemistry.
    Engel AG; Lambert EH; Mulder DM; Gomez MR; Whitaker JN; Hart Z; Sahashi K
    Ann N Y Acad Sci; 1981; 377():614-39. PubMed ID: 6280566
    [No Abstract]   [Full Text] [Related]  

  • 32. [Ways in which chemicals can affect cholinergic nerve endings].
    Prozorovskiĭ VB
    Usp Fiziol Nauk; 1980; 11(2):26-48. PubMed ID: 6249048
    [No Abstract]   [Full Text] [Related]  

  • 33. Acetylcholinesterase inhibitors in MG: to be or not to be?
    Punga AR; Stålberg E
    Muscle Nerve; 2009 Jun; 39(6):724-8. PubMed ID: 19260048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced acetylcholine receptors in myasthenia gravis.
    Drachman DB; Fambrough DM; Satyamurti S
    Trans Am Neurol Assoc; 1973; 98():93-5. PubMed ID: 4361781
    [No Abstract]   [Full Text] [Related]  

  • 35. Heterogeneity of neuromuscular junctions in striated muscle of human esophagus demonstrated by triple staining for the vesicular acetylcholine transporter, alpha-bungarotoxin, and acetylcholinesterase.
    Kallmünzer B; Sörensen B; Neuhuber WL; Wörl J
    Cell Tissue Res; 2006 May; 324(2):181-8. PubMed ID: 16437206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myasthenia gravis: demonstration of membrane attack complex in muscle end-plates.
    Fazekas A; Komoly S; Bózsik B; Szobor A
    Clin Neuropathol; 1986; 5(2):78-83. PubMed ID: 3519034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Congenital endplate acetylcholinesterase deficiency.
    Hutchinson DO; Walls TJ; Nakano S; Camp S; Taylor P; Harper CM; Groover RV; Peterson HA; Jamieson DG; Engel AG
    Brain; 1993 Jun; 116 ( Pt 3)():633-53. PubMed ID: 8390325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Congenital myasthenic syndromes.
    Harper CM
    Semin Neurol; 2004 Mar; 24(1):111-23. PubMed ID: 15229798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The motor end-plate in ocular and generalized myasthenia gravis: a quantitative ultrastructural study (author's transl)].
    Tsujihata M; Hazama R; Takamori M; Shibuya N; Mori K
    Rinsho Shinkeigaku; 1978 Mar; 18(3):149-56. PubMed ID: 668254
    [No Abstract]   [Full Text] [Related]  

  • 40. The spectrum of congenital end-plate acetylcholinesterase deficiency.
    Hutchinson DO; Engel AG; Walls TJ; Nakano S; Camp S; Taylor P; Harper CM; Brengman JM
    Ann N Y Acad Sci; 1993 Jun; 681():469-86. PubMed ID: 8395162
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.